Zacks Investment Management Organogenesis Holdings Inc. Transaction History

Zacks Investment Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$9.02 - $13.5 $405,115 - $606,325	-44,913 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.71 - $17.18 $2,179 - $2,731	-159 Reduced 0.35%	44,913 $640,000
Q2 2021 Aug 16, 2021	SELL	$14.92 - $23.23 $142,769 - $222,287	-9,569 Reduced 17.51%	45,072 $749,000
Q1 2021 May 17, 2021	SELL	$7.33 - $21.06 $213,039 - $612,087	-29,064 Reduced 34.72%	54,641 $996,000
Q4 2020 Feb 16, 2021	BUY	$3.63 - $7.53 $303,849 - $630,298	83,705 New	83,705 $630,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $408M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.